Loading
Exhibitor profile image for Swiss Business Hub USA
Affiliated with the Swiss Embassy, the Swiss Business Hub USA represents Switzerland Global Enterprise (S-GE) in the United States. S-GE works all over the world to support entrepreneurs and promote S ...
Exhibitor profile image for FreeMind Investments
FreeMind Investments (FMI) is a venture capital fund established in partnership between the FreeMind Group and Daewoong Pharmaceuticals.
Exhibitor profile image for HIV + Hepatitis Policy Institute
MISSION STATEMENT: The HIV+Hepatitis Policy Institute promotes quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions.
Exhibitor profile image for HK Winhealth Pharma Group
HK WinHealth Pharma Group is a leading, fully integrated commercialization platform focused on bringing innovative and specialty therapies to Greater China and Asia‑Pacific. Our strengths span hematol ...
Exhibitor profile image for International Finance Corporation
IFC, a member of the World Bank Group, is the largest global development institution focused exclusively on the private sector development.
Exhibitor profile image for Meiji Pharma USA Inc.
Meiji Pharma USA Inc., a subsidiary of Japan-based Meiji Seika Pharma Co., Ltd., is a specialized pharmaceutical company focused on infectious diseases, hematological malignancies, autoimmune disease ...
Exhibitor profile image for MSQ Ventures
MSQ Ventures, established in 2016, is a New York headquartered, biopharma transaction focused boutique investment and advisory firm, with offices in US & China. While we directly invest in global life ...
Exhibitor profile image for Qilu Pharmaceuticals
Qilu Pharmaceutical is a top 3 pharma company in China. We cover diverse therapeutic areas with a focus on oncology, cardiovascular and metabolic diseases, immunology, infectious diseases, and CNS dis ...
Exhibitor profile image for Investment NSW
With Australia's largest population, strongest economy , and innovative life sciences sector, New South Wales (NSW) is open for business for companies looking to expand in Australia and the Asia-Pacif ...
Exhibitor profile image for Soligenix, Inc.
Soligenix lead candidate, HyBryte™ (synthetic hypericin), for the treatment of early stage cutaneous T-cell lymphoma (CTCL) has already demonstrated positive and statistically signficant results in it ...
437 Results